12-49295226-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000257860.9(PRPH):c.26G>A(p.Arg9Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,611,522 control chromosomes in the GnomAD database, including 254 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000257860.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRPH | NM_006262.4 | c.26G>A | p.Arg9Gln | missense_variant | 1/9 | ENST00000257860.9 | NP_006253.2 | |
TROAP-AS1 | NR_120449.1 | n.2812+34C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRPH | ENST00000257860.9 | c.26G>A | p.Arg9Gln | missense_variant | 1/9 | 1 | NM_006262.4 | ENSP00000257860.4 | ||
TROAP-AS1 | ENST00000553259.1 | n.2812+34C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0101 AC: 1533AN: 152190Hom.: 17 Cov.: 33
GnomAD3 exomes AF: 0.0146 AC: 3456AN: 236798Hom.: 57 AF XY: 0.0161 AC XY: 2094AN XY: 130034
GnomAD4 exome AF: 0.0120 AC: 17536AN: 1459214Hom.: 235 Cov.: 31 AF XY: 0.0130 AC XY: 9430AN XY: 725872
GnomAD4 genome AF: 0.0101 AC: 1541AN: 152308Hom.: 19 Cov.: 33 AF XY: 0.00999 AC XY: 744AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:4Other:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 11, 2018 | This variant is associated with the following publications: (PMID: 15322088, 25588603, 27884173, 28430856) - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | PRPH: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Amyotrophic lateral sclerosis type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 17, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at